560 related articles for article (PubMed ID: 14551028)
1. NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant.
Zhou W; Ohdan H; Tanaka Y; Hara H; Tokita D; Onoe T; Asahara T
Transpl Immunol; 2003; 12(1):9-18. PubMed ID: 14551028
[TBL] [Abstract][Full Text] [Related]
2. Production of anti-ABO blood group antibodies after minor ABO-incompatible bone marrow transplantation in NOD/SCID/gamma(c)(null) mice.
Tomita H; Fuchimoto Y; Mori T; Kato J; Uemura T; Handa M; Tazawa H; Ohdan H; Okamoto S; Kuroda T
Clin Transplant; 2013; 27(6):E702-8. PubMed ID: 24125194
[TBL] [Abstract][Full Text] [Related]
3. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
[TBL] [Abstract][Full Text] [Related]
4. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
5. Porcine cell microchimerism but lack of productive porcine endogenous retrovirus (PERV) infection in naive and humanized SCID-beige mice treated with porcine peripheral blood mononuclear cells.
Kuddus RH; Metes DM; Nalesnik MA; Logar AJ; Rao AS; Fung JJ
Transpl Immunol; 2004; 13(1):15-24. PubMed ID: 15203124
[TBL] [Abstract][Full Text] [Related]
6. Human hematopoietic stem/progenitor cells generate CD5+ B lymphoid cells in NOD/SCID mice.
Novelli EM; Ramírez M; Leung W; Civin CI
Stem Cells; 1999; 17(5):242-52. PubMed ID: 10527459
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.
Yoshino H; Ueda T; Kawahata M; Kobayashi K; Ebihara Y; Manabe A; Tanaka R; Ito M; Asano S; Nakahata T; Tsuji K
Bone Marrow Transplant; 2000 Dec; 26(11):1211-6. PubMed ID: 11149733
[TBL] [Abstract][Full Text] [Related]
8. Antilymphoma activity of human gamma delta T-cells in mice with severe combined immune deficiency.
Malkovska V; Cigel FK; Armstrong N; Storer BE; Hong R
Cancer Res; 1992 Oct; 52(20):5610-6. PubMed ID: 1394184
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor promotes human T-cell development in nonobese diabetic/severe combined immunodeficient mice.
Samira S; Ferrand C; Peled A; Nagler A; Tovbin Y; Ben-Hur H; Taylor N; Globerson A; Lapidot T
Stem Cells; 2004; 22(6):1085-100. PubMed ID: 15536198
[TBL] [Abstract][Full Text] [Related]
10. Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice.
Christianson SW; Greiner DL; Schweitzer IB; Gott B; Beamer GL; Schweitzer PA; Hesselton RM; Shultz LD
Cell Immunol; 1996 Aug; 171(2):186-99. PubMed ID: 8806787
[TBL] [Abstract][Full Text] [Related]
11. NOD/LtSz-Rag1nullPfpnull mice: a new model system with increased levels of human peripheral leukocyte and hematopoietic stem-cell engraftment.
Shultz LD; Banuelos S; Lyons B; Samuels R; Burzenski L; Gott B; Lang P; Leif J; Appel M; Rossini A; Greiner DL
Transplantation; 2003 Oct; 76(7):1036-42. PubMed ID: 14557749
[TBL] [Abstract][Full Text] [Related]
12. Calcineurin inhibitors block B-1 cell differentiation: the relevance to immunosuppressive treatment in ABO-incompatible transplantation.
Zhou W; Ohdan H; Asahara T
Transplant Proc; 2005 May; 37(4):1808-11. PubMed ID: 15919474
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the NOD/scid-[Tg]DR1 mouse expressing HLA-DRB1*01 transgene: a model of SCID-hu mouse for vaccine development.
Camacho RE; Wnek R; Fischer P; Shah K; Zaller DM; Woods A; La Monica N; Aurisicchio L; Fitzgerald-Bocarsly P; Koo GC
Exp Hematol; 2007 Aug; 35(8):1219-30. PubMed ID: 17662890
[TBL] [Abstract][Full Text] [Related]
14. Engraftment of human T, B and NK cells in CB.17 SCID/beige mice by transfer of human spleen cells.
Yacoub-Youssef H; Marcheix B; Calise D; Thiers JC; Therville N; Benoist H; Blaes N; Ségui B; Dambrin C; Thomsen M
Transpl Immunol; 2005 Dec; 15(2):157-64. PubMed ID: 16412960
[TBL] [Abstract][Full Text] [Related]
15. Human antibody response in human peripheral blood leukocyte/severe combined immunodeficient chimeric model is dependent on B and T cell costimulation via CD40/CD40 ligand.
Chen FA; Williams SS; Fanslow WC; Bankert RB
J Immunol; 1995 Sep; 155(6):2833-40. PubMed ID: 7673699
[TBL] [Abstract][Full Text] [Related]
16. [Establishment of an xenogeneic acute graft-versus-host disease model in NOD/SCID mice by engraftment of G-CSF mobilized human mononuclear cells].
Gao L; Wang JM; Xie LN; Zhou H; Qiu HY
Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):87-91. PubMed ID: 18681307
[TBL] [Abstract][Full Text] [Related]
17. Characterization of human B cells in umbilical cord blood-transplanted NOD/SCID mice.
Wang X; Qi Z; Wei H; Tian Z; Sun R
Transpl Immunol; 2012 Mar; 26(2-3):156-62. PubMed ID: 22198522
[TBL] [Abstract][Full Text] [Related]
18. Antibody responses to the blood group antigen D in SCID mice reconstituted with human blood mononuclear cells.
Leader KA; Macht LM; Steers F; Kumpel BM; Elson CJ
Immunology; 1992 Jun; 76(2):229-34. PubMed ID: 1634246
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model.
Cao T; Lazdina U; Desombere I; Vanlandschoot P; Milich DR; Sällberg M; Leroux-Roels G
J Virol; 2001 Jul; 75(14):6359-66. PubMed ID: 11413302
[TBL] [Abstract][Full Text] [Related]
20. Intra-thymic/splenic engraftment of human T cells in HLA-DR1 transgenic NOD/scid mice.
Camacho RE; Wnek R; Shah K; Zaller DM; O'Reilly RJ; Collins N; Fitzgerald-Bocarsly P; Koo GC
Cell Immunol; 2004; 232(1-2):86-95. PubMed ID: 15922719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]